Labhead CELLinib GmbH
Labhead CELLinib GmbH
Lena Marie Berger was born in 1995 in Essen, Germany. She studied Biology at the Freie University Berlin where she received her Bachelor of Science in 2016. During her Bachelor’s she worked in the Structural Genomics Consortium Oxford (University of Oxford) on the characteriztaion of protein kinase activators and in the Max Planck Institute for Coloids and Interfaces on the characterization of binders of lectins. She gained a Master’s of biological sciences from the Goethe University Frankfurt and did her thesis on inhibitor characterization at Merck KgaA in Darmstadt in 2019. She then set out to get her PhD in pharmaceutical chemistry in the lab of Prof. Dr. Stefan Knapp where she investigated the cellular selectivity profiles of inhibitors across the kinome using the in-cell technology NanoBRET. She now wants to make these services available to improve the understanding of kinase inhibitor profiles in living cells.
